Chemoinformaics analysis of FLAVAN-3-OL
Molecular Weight | 226.275 | nRot | 1 |
Heavy Atom Molecular Weight | 212.163 | nRig | 17 |
Exact Molecular Weight | 226.099 | nRing | 3 |
Solubility: LogS | -3.272 | nHRing | 1 |
Solubility: LogP | 3.003 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
nHA | 2 | APOL | 35.9891 |
nHD | 1 | BPOL | 15.7809 |
QED | 0.81 |
Synth | 2.588 |
Natural Product Likeliness | 1.092 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.016 |
Pgp-sub | 0 |
HIA | 0.013 |
CACO-2 | -4.785 |
MDCK | 0.0000158 |
BBB | 0.534 |
PPB | 0.961017 |
VDSS | 1.141 |
FU | 0.0276907 |
CYP1A2-inh | 0.458 |
CYP1A2-sub | 0.603 |
CYP2c19-inh | 0.852 |
CYP2c19-sub | 0.288 |
CYP2c9-inh | 0.393 |
CYP2c9-sub | 0.588 |
CYP2d6-inh | 0.051 |
CYP2d6-sub | 0.608 |
CYP3a4-inh | 0.084 |
CYP3a4-sub | 0.623 |
CL | 8.906 |
T12 | 0.21 |
hERG | 0.042 |
Ames | 0.383 |
ROA | 0.048 |
SkinSen | 0.097 |
Carcinogencity | 0.748 |
EI | 0.692 |
Respiratory | 0.032 |
NR-Aromatase | 0.65 |
Antiviral | No |
Prediction | 0.713745 |